You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cancer Genomics

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypoxia-driven Prostate Cancer Genomics (HYPROGEN)

Recruiting
  • Prostate Cancer
  • Hypoxia
  • Optional non-IMP pimonidazole
  • +8 more
  • Manchester, United Kingdom
    The Christie NHS Foundation Trust
Jan 26, 2023

Hispanic Patient Engagement in Colorectal Cancer Genomics,

Recruiting
  • Colorectal Carcinoma
  • Archive Sample Retrieval
  • +4 more
  • Los Angeles, California
  • +1 more
Sep 25, 2023

GI Cancer, Liver Cancer Trial in Tainan

Recruiting
  • GI Cancer
  • Liver Cancer
    • Tainan, Taiwan
    • +1 more
    Mar 2, 2023

    COGNITION: Genomics-Guided Precision Oncology in Early High-Risk

    Recruiting
    • Early-Stage Breast Cancer
    • Neoadjuvant Therapy
    • Genomic Profiling / Sequencing
    • Berlin, Germany
    • +4 more
    Jun 19, 2023

    Breast Cancer and Other Gynecologic Malignancies

    Enrolling by invitation
    • Breast Cancer
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 18, 2022

      Early-stage Breast Cancer Trial in Heidelberg (Atezolizumab 1200 mg in 20 ML Injection, Inavolisib, Ipatasertib)

      Not yet recruiting
      • Early-stage Breast Cancer
      • Atezolizumab 1200 mg in 20 ML Injection
      • +5 more
      • Heidelberg, Baden-Wuerttemberg, Germany
        National Center for Tumor Diseases
      Sep 13, 2022

      Precision-Based Genomics in Prostate Cancer

      Recruiting
      • Prostate Cancer
        • La Jolla, California
        • +4 more
        Jul 28, 2022

        Prostate Cancer Trial run by the National Cancer Institute (NCI) (mpMRI)

        Recruiting
        • Prostate Cancer
        • mpMRI
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Aug 24, 2022

        Lymphoma Trial in Houston (Molecular Functional Portrait)

        Recruiting
        • Lymphoma
        • Molecular Functional Portrait
        • Houston, Texas
          M D Anderson Cancer Center
        Jul 14, 2022

        Gastrointestinal Cancer, Lymphoma, Thoracic Cancer Trial in Boston, Brighton, Methuen (SURGE, Standard of Care)

        Not yet recruiting
        • Gastrointestinal Cancer
        • +2 more
        • SURGE
        • Standard of Care
        • Boston, Massachusetts
        • +2 more
        May 11, 2022

        Breast Carcinoma, Colorectal Carcinoma, Lung Carcinoma Trial in Duarte (Best Practice, Educational Intervention, Genomic

        Recruiting
        • Breast Carcinoma
        • +6 more
        • Best Practice
        • +3 more
        • Duarte, California
          City of Hope Medical Center
        Feb 11, 2022

        NSCLC Metastatic, NSCLC Stage III Trial in Worldwide (Avelumab, Axitinib, Palbociclib)

        Active, not recruiting
        • Non-small Cell Lung Cancer Metastatic
        • Non-small Cell Lung Cancer Stage III
        • La Jolla, California
        • +5 more
        Aug 12, 2022

        ctDNA and Organ Preservation/Pathologic CR in Rectal Cancer

        Not yet recruiting
        • Rectal Cancer
        • Non Metastatic Rectal Cancer
        • ctDNA
        • Boston, Massachusetts
        • +1 more
        Nov 17, 2022

        Metastatic Breast Cancer, Recurrent Ovarian Carcinoma Trial in Salt Lake City, Fairfax (Ribociclib, Belinostat)

        Recruiting
        • Metastatic Breast Cancer
        • Recurrent Ovarian Carcinoma
        • Salt Lake City, Utah
        • +1 more
        May 3, 2022

        Genetic Predisposition to Disease, Genetic Predisposition Trial in Boston (Nest Platform)

        Not yet recruiting
        • Genetic Predisposition to Disease
        • Genetic Predisposition
        • Nest Platform
        • Boston, Massachusetts
          Dana Farber Cancer Institute
        Mar 6, 2023

        CATCH: Implementation of Genomics-guided Precision Medicine in

        Recruiting
        • Metastatic Breast Cancer
        • Genomic Profiling / Sequencing
        • Berlin, Germany
        • +4 more
        Dec 7, 2022

        Genomic Structural Variation in Cancer Susceptibility

        Active, not recruiting
        • Breast Cancer
        • +5 more
          • New York, New York
            Memorial Sloan Kettering Cancer Center
          Dec 23, 2022

          Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic Trial in Scottsdale (Botensilimab, Balstilimab, Chloroquine

          Not yet recruiting
          • Pancreatic Cancer Metastatic
          • Pancreatic Adenocarcinoma Metastatic
          • Scottsdale, Arizona
            Clinical Trials Nurse Navigator
          Oct 3, 2023

          Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in

          Completed
          Has Results
          • Recurrent Acute Leukemia of Ambiguous Lineage
          • +5 more
          • Chemosensitivity Assay
          • +4 more
          • Seattle, Washington
            Fred Hutch/University of Washington Cancer Consortium
          Jun 29, 2022

          Using Genomics in Inherited Bone Marrow Failure (IBMDx Study)

          Recruiting
          • Inherited BMF Syndrome
          • +2 more
          • whole genome and transcriptome sequencing
          • Melbourne, Victoria, Australia
            Peter MacCallum Cancer Centre
          Mar 28, 2022

          Prostate Cancer Trial in United States (Decipher Prostate Cancer Classifier)

          Active, not recruiting
          Has Results
          • Prostate Cancer
          • Decipher Prostate Cancer Classifier
          • Ann Arbor, Michigan
          • +12 more
          Aug 26, 2022

          Pancreatic Cancer Trial in San Diego (Early detection pancreatic cancer test, Early detection pancreatic cancer test and MRI

          Not yet recruiting
          • Pancreatic Cancer
          • Early detection pancreatic cancer test
          • Early detection pancreatic cancer test and MRI Imaging
          • San Diego, California
            Bluestar Genomics, Inc.
          Dec 27, 2021

          Cancer of Pancreas Trial in Dallas (Bemcentinib, Nab-paclitaxel, Gemcitabine)

          Terminated
          • Cancer of Pancreas
          • Dallas, Texas
            University of Texas Southwestern Medical Center
          Sep 26, 2022

          DOvEEgene: Diagnosing Ovarian and Endometrial Cancer Early Using

          Recruiting
          • Ovarian Neoplasms
          • +8 more
            • Montreal, Quebec, Canada
            • +1 more
            Oct 14, 2021

            Cancer Trial in Dallas

            Recruiting
            • Cancer
              • Dallas, Texas
                Baylor Scott & White Research Institute
              May 11, 2022